About this Journal Submit a Manuscript Table of Contents
Case Reports in Pediatrics
Volume 2012 (2012), Article ID 624168, 5 pages
http://dx.doi.org/10.1155/2012/624168
Case Report

Mycophenolate Mofetil-Related Enterocolitis and Weight Loss: A Pediatric Case Series

1Division of Gastroenterology Hepatology and Nutrition, Cincinnati Children’s, 3333 Burnet Avenue MLC 2010, Cincinnati, OH 45229-3039, USA
2Division of Gastroenterology, University of Southern California, 4650 Sunset Boulevard, MS #126, Los Angeles, CA 90027, USA
3Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Vanderbilt University School of Medicine, 2200 Children's Way, 11th Floor, Doctors' Office Tower, Nashville, TN 37232-2576, USA
4Seacoast Pathology, Aurora Diagnostics, 1 Hampton Road, Suite 208, Exeter, NH 03833-4849, USA
5Division of Gastroenterology, Oschner Children’s Health Center, 1315 Jefferson Highway, New Orleans, LA 70121, USA
6Division of Pediatric Gastroenterology and Nutrition Sciences, University of Alabama at Birmingham, 1600 7th Avenue. S., Lowder Blgd., Ste. 618, Birmingham, AL 35233, USA
7Department of Nephrology, University of Minnesota, Pediatric Specialty Care Discovery Clinic, 2512 Building, 2512 S. 7th Street, Minneapolis, MN 55454, USA
8Division of Pediatric Nephrology, Vanderbilt University School of Medicine, 2200 Children's Way, 11th Floor, Doctors' Office Tower, Nashville, TN 37232, USA
9Department of Pathology, University of Arizona, 1501 N. Campbell Avenue, P.O. Box 245108, Tucson, AZ 85724-5108, USA

Received 10 August 2012; Accepted 6 September 2012

Academic Editors: E. Czkwianianc, A. W. Kamps, and D. I. Zafeiriou

Copyright © 2012 Dana M. H. Dykes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Quéméneur, M. Flacher, L. M. Gerland, M. Ffrench, J. P. Revillard, and N. Bonnefoy-Berard, “Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis,” Journal of Immunology, vol. 169, no. 5, pp. 2747–2755, 2002. View at Scopus
  2. P. F. Halloran, “Molecular mechanisms of new immunosuppressants,” Clinical Transplantation, vol. 10, no. 1, pp. 118–123, 1996. View at Scopus
  3. W. D. Simmons, S. C. Rayhill, and H. W. Sollinger, “Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection,” Drug Safety, vol. 17, no. 2, pp. 75–92, 1997. View at Scopus
  4. J. C. Papadimitriou, C. B. Cangro, A. Lustberg et al., “Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern,” International Journal of Surgical Pathology, vol. 11, no. 4, pp. 295–302, 2003. View at Scopus
  5. U. P. Phatak, P. Seo-Mayer, D. Jain, M. Selbst, S. Husain, and D. S. Pashankar, “Mycophenolate mofetil-induced colitis in children,” Journal of Clinical Gastroenterology, vol. 43, no. 10, pp. 967–969, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. M. Sollid and B. A. Lie, “Celiac disease genetics: current concepts and practical applications,” Clinical Gastroenterology and Hepatology, vol. 3, no. 9, pp. 843–851, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. B. D. Maes, I. Dalle, K. Geboes et al., “Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea,” Transplantation, vol. 75, no. 5, pp. 665–672, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Al-shamma, M. Fox, F. Campbell, P. Collins, and M. Lombard, “Diarrhoea and weight loss in an immunosuppressed patient,” Gut, vol. 59, no. 9, pp. 1225–1302, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. E. C. Gorospe, “Chronic diarrhoea from mycophenolate mofetil-induced colitis,” BMJ Case Reports. In press. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. Skelly, R. F. A. Logan, D. Jenkins, Y. R. Mahida, and C. J. Hawkey, “Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 8, no. 2, pp. 93–97, 2002. View at Scopus
  11. D. Ducloux, Y. Ottignon, S. Semhoun-Ducloux et al., “Mycophenolate mofetil-induced villous atrophy,” Transplantation, vol. 66, no. 8, pp. 1115–1116, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Kamar, P. Faure, E. Dupuis et al., “Villous atrophy induced by mycophenolate mofetil in renal-transplant patients,” Transplant International, vol. 17, no. 8, pp. 463–467, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. K. Selbst, W. A. Ahrens, M. E. Robert, A. Friedman, D. D. Proctor, and D. Jain, “Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil,” Modern Pathology, vol. 22, no. 6, pp. 737–743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Arns, S. Breuer, S. Choudhury et al., “Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil,” Clinical Transplantation, vol. 19, no. 2, pp. 199–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. T. Wan Song, E. Abdala, P. Rodrigues Bonazzi, T. Bacchella, and M. C. C. Machado, “Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?–a mini-review,” Brazilian Journal of Infectious Diseases, vol. 10, no. 2, pp. 132–138, 2006. View at Scopus